ArticlePharmaceutics2026

Liposomal CRISPR/Cas9-Mediated Local Genome Editing for Joint Disease in Mucopolysaccharidosis Type I.

Hallana Souza Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.